4-甲基癸烷-1-醛 | 80699-63-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 4-甲基癸烷-1-醛
• 中文别名: (4aS,7S,7aR)-4,7-二甲基-5,6,7,7a-四氢环戊二烯并[c]吡喃-1(4aH)-酮
• 英文名称: 4-methyldecanal
• 英文别名: 4-methyl-decanal；4-Methyldecan-1-al
• CAS: 80699-63-4
• 化学式: C₁₁H₂₂O
• 分子量: 170.295
• InChiKey: UASJZAYRKLUVLT-UHFFFAOYSA-N

物化性质

• 熔点：
  -2°C (estimate)
• 沸点：
  229.96°C (estimate)
• 密度：
  0.8374 (estimate)
• LogP：
  4.442 (est)

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  12
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.91
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4-甲基癸烷-1-醛 在 sodium tetrahydroborate 作用下， 以 甲醇 为溶剂， 反应 0.25h， 以96%的产率得到4-methyl-1-decanol
  参考文献：
  名称：

  Ultrasound Assisted Synthesis of 5,9-Dimethylpentadecane and 5,9-Dimethylhexadecane – the Sex Pheromones of Leucoptera coffeella

  摘要：

  使用超声波照射，从香茅醇合成了主要的和次要的性信息素成分，梨小食心虫性信息素的消旋5,9-二甲基十五烷和5,9-二甲基十六烷，总产率为56-58%，经过六个步骤。超声波照射有效地促进了醇的甲苯磺酰化（两步）以及随后与相应的格氏试剂的交叉偶联反应（也是两步）。

  DOI：

  10.3390/12082080
• 作为产物：
  描述：

  4-methyl-4-nitro-1-decanal 在 偶氮二异丁腈 、 三正丁基氢锡 作用下， 以 苯 为溶剂， 反应 2.0h， 以78%的产率得到4-甲基癸烷-1-醛
  参考文献：
  名称：

  New synthetic methods. Conjugate addition of alkyl groups to electron deficient olefins with nitroalkanes as alkyl anion equivalents

  摘要：

  DOI：

  10.1021/jo00220a003

文献信息

• Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside
  申请人：——

  公开号：US20020193314A1

  公开（公告）日：2002-12-19

  A desired isomer is selectively prepared by phosphorolyzing and isomerizing an anomer mixture of a 1-phosphorylated saccharide derivative while crystallizing one of the isomers to displace the equilibrium. Furthermore, using the action of a nucleoside phosphorylase, a nucleoside is prepared from the 1-phosphorylated saccharide derivative obtained and a base with improved stereoselectivity and a higher yield. This process is an anomer-selective process for preparing a 1-phosphorylated saccharide derivative and a nucleoside.

  通过磷酸解和异构化1-磷酸化糖衍生物的环式异构体混合物，有选择性地制备所需的异构体，同时通过结晶其中一种异构体以移动平衡。此外，利用核苷酸磷酸化酶的作用，从获得的1-磷酸化糖衍生物和一种改善立体选择性和更高产率的碱基中制备核苷酸。该过程是用于制备1-磷酸化糖衍生物和核苷酸的环式选择性过程。
• Piperidine derivatives
  申请人：SANKYO COMPANY LIMITED

  公开号：EP0583971A1

  公开（公告）日：1994-02-23

  Compounds of formula (I): wherein:    R represents H or a mono- or poly- carboxylic acyl group;    R¹ represents H or a carboxylic ester moiety;    R² represents an alkyl group, an alkenyl group, an alkynyl group, an aryl group, or an aralkyl group, said groups being optionally substituted, or R² represents a carboxylic ester moiety;    n = 1 - 4;    Y is O or S;    and esters thereof,    are useful as heat and photo- stabilisers for polymeric materials.

  式(I)的化合物：其中：R代表H或单酰基或多酰基群；R¹代表H或羧酸酯基；R²代表烷基、烯基、炔基、芳基或芳基烷基，这些基团可选择性地被取代，或者R²代表羧酸酯基；n = 1 - 4；Y为O或S；及其酯，可用作聚合材料的热稳定剂和光稳定剂。
• Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use
  申请人：Sankyo Company Limited

  公开号：EP0536936A1

  公开（公告）日：1993-04-14

  Compounds of formula (I): [in which: R¹, R² and R³ are the same or different and each represents a hydrogen atom, an optionally substituted alkanoyl group or an alkenylcarbonyl group, provided that at least one of R¹, R² and R³ represents an unsubstituted alkanoyl group having from 5 to 24 carbon atoms, said substituted alkanoyl group or said alkenylcarbonyl group; and one of R⁴ and R⁵ represents a hydrogen atom and the other represents a cyano group]; have valuable anti-tumour activity.

  式子（I）的化合物：[其中：R¹、R²和R³相同或不同，每个代表氢原子、可选取代的脂肪酰基团或烯基羰基团，前提是至少有一个R¹、R²和R³代表有5到24个碳原子的未取代脂肪酰基团，或者是所述取代的脂肪酰基团或所述烯基羰基团；R⁴和R⁵中的一个代表氢原子，另一个代表氰基]，具有有价值的抗肿瘤活性。
• Selective process for producing an anomer of a 1-phosphorylated saccharide derivative and process for producing a nucleoside
  申请人：Komatsu Hironori

  公开号：US20060094869A1

  公开（公告）日：2006-05-04

  A desired isomer is selectively prepared by phosphorolyzing and isomerizing an anomer mixture of a 1-phosphorylated saccharide derivative while crystallizing one of the isomers to displace the equilibrium. Furthermore, using the action of a nucleoside phosphorylase, a nucleoside is prepared from the 1-phosphorylated saccharide derivative obtained and a base with improved stereoselectivity and a higher yield. This process is an anomer-selective process for preparing a 1-phosphorylated saccharide derivative and a nucleoside.

  通过磷酸解和异构化1-磷酸化糖衍生物的异构体混合物，有选择性地制备所需的异构体，并结晶其中一种异构体以移动平衡。此外，利用核苷酸磷酸化酶的作用，从所得的1-磷酸化糖衍生物和碱基中制备核苷，具有改善的立体选择性和更高的产量。该过程是一种选择性异构过程，用于制备1-磷酸化糖衍生物和核苷。
• Lipid A analogues having immunoactivating and anti-tumour activity
  申请人：Sankyo Company Limited

  公开号：EP0437016A2

  公开（公告）日：1991-07-17

  Compounds of formula (I): [in which: R1 is hydroxy, protected hydroxy, fluorine, or -OP(0)(OH)2; R2 and R3 are independently optionally substituted C6 - C20 aliphatic acyl; R4 is hydroxy, protected hydroxy, or -OP(O)(OH)2, where at least one of R1 and R4 is -OP(O)(OH)2; and R5 is hydroxy, protected hydroxy, or fluorine; provided that, except where at least one of R1 and R5 is fluorine, then at least one of R2 and R3 is a substituted C6 - C20 aliphatic acyl having (i) at least one halogen substituent and (ii) at least one of halogen, hydroxy and C6 - C20 aliphatic acyloxy or at least one of R2 and R3 is a substituted C6 - C20 aliphatic acyl which is substituted by at least one halogen-substituted C6 - C20 aliphatic carboxylic acyloxy]; have Lipid A-like activity and may be used for the treatment, prophylaxis, diagnosis and support of an animal suffering a disease or disorder arising from a deficiency in the immune system or from a tumor. They may be prepared by phosphorylation of corresponding compounds lacking a phosphoryl group.

  式(I)化合物： 其中R1 是羟基、受保护的羟基、氟或-OP(0)(OH)2；R2 和 R3 独立地是任选取代的 C6 - C20 脂肪族酰基；R4 是羟基、受保护的羟基或-OP(O)(OH)2，其中 R1 和 R4 中至少有一个是-OP(O)(OH)2；R5 是羟基、受保护的羟基或氟；条件是，除非 R1 和 R5 中至少有一个是氟，否则 R2 和 R3 中至少有一个是被取代的 C6 - C20 脂肪族酰基，该酰基具有 (i) 至少一个卤素取代基和 (ii) 卤素、羟基和 C6 - C20 脂肪族酰氧基中的至少一个，或者 R2 和 R3 中至少有一个是被至少一个卤素取代的 C6 - C20 脂肪族羧基酰氧基取代的 C6 - C20 脂肪族酰基]；具有类似脂质 A 的活性，可用于治疗、预防、诊断和支持因免疫系统缺陷或肿瘤引起的疾病或紊乱的动物。它们可以通过对缺乏磷酸基团的相应化合物进行磷酸化来制备。